API Ozagrel 82571-53-7

Description:

Ozagrel, medicamentum antithrombicum, est potens et selectivum TXA Synthase (thromboxane A2) inhibitor valde activus in plateis humanis.Ozagrel activitatem locomotoris emendavit et coordinationem in ischemia-reperfusion, mures exempla laesa est et potentialem usum therapeuticum ad ictum habet.

Contactus: Erica Zheng

Email: erica@zhuoerchem.com

Tel: +86 21 2097 0332

Mob: +86 177 1767 9251

Whatsapp: LXXXVI CLXXXVI 2503 (LX)XLIII (WeChat & Telegram & Line)

Skype: slhyzy

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio

Ozagrel tractare dolorem pulmonis.Operatur minuendo dolorem patientis.

Specificatio:

Product Name	Ozagrel
Nomen chemicum	(E) -4-(1-Imidazoylmethyl) acidum cinnamicum
Alia Nomen	2-Propenoicacid,3-[4-(1H-imidazol-1-ylmethyl)phenyl]-,(2E)-;(E)-3-[4-(1H-Imidazol-1-ylmethyl)phenyl]propenoicacid;( E)-3-[p-(1H-Imidazol-1-ylmethyl)phenyChemicalbookl]acrylicacidum;3-[4-(1H-IMIDAZOL-1-YLMETHYL)PHENYL]-2E-PROPENOICACID;OZAGRELAPI;OZAGREL(OKY-046) ;(2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoicacid
CAS Number	82571-53-7
Formulae hypotheticae	C13H12N2O2
Formula Pondus	228.25
Aspectus	Album aut album-sicut crystallinum pulveris
Assay	98.0% min
Liquescens punctum	223-224 °C
Ferveret	468.0± 25.0 °C
Density	1.17±0.1 g/cm3
sarcina	20kg/peram/orum, 25kg/peram/orum, vel quod requiris
Repono	Repone continens arcte clausus in loco sicco & frigido.Non exponere solis dirigere.
COA & MSDS	Praesto
Applicationem	Ad investigationes propositum